The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough
At 0.25mg per week, you use just 1mg before the 28-day expiration, wasting 9mg
Why to Avoid: Fried and greasy foods are high in unhealthy fats, leading to digestive discomfort, and may counteract the appetite-suppressing effects of tirzepatide
NAION is an eye condition that can develop without warning and cause irreversible blindness in one or both eyes
Overview of the TrimRx Telehealth Evaluation and Prescription Process According to the company's published FAQ and process descriptions, the TrimRx program begins with a digital medical intake questionnaire designed to collect information about health history, current medications, weight management goals, and other relevant health factors
Women using oral contraceptives should be advised to use additional contraception for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase, or consider non-oral contraceptive methods, as tirzepatide may reduce the effectiveness of oral contraceptives